scutellarin has been researched along with Cardiotoxicity in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chi, M; Guo, C; Han, Y; Huo, Y; Sun, X; Xin, B; Yang, Q; Zhou, L | 1 |
| Chi, M; Guo, C; Han, Y; Li, X; Sun, X; Wang, Y; Xin, B; Yang, Q; Zhou, L | 1 |
| Guo, C; Han, YL; Huo, Y; Sun, XP; Wan, LL; Yang, QJ | 1 |
3 other study(ies) available for scutellarin and Cardiotoxicity
| Article | Year |
|---|---|
Scutellarin attenuates doxorubicin-induced oxidative stress, DNA damage, mitochondrial dysfunction, apoptosis and autophagy in H9c2 cells, cardiac fibroblasts and HUVECs.
Topics: Animals; Antibiotics, Antineoplastic; Apigenin; Apoptosis; Autophagy; Cardiotoxicity; DNA Damage; Doxorubicin; Fibroblasts; Glucuronates; Human Umbilical Vein Endothelial Cells; Humans; Mitochondria; Myocytes, Cardiac; Oxidative Stress; Rats | 2022 |
Scutellarin Attenuates Doxorubicin-Induced Cardiotoxicity by Inhibiting Myocardial Fibrosis, Apoptosis and Autophagy in Rats.
Topics: Animals; Apoptosis; Autophagy; Cardiotoxicity; Doxorubicin; Fibrosis; Rats; Stroke Volume; Ventricular Function, Left | 2023 |
Scutellarin protects against doxorubicin-induced acute cardiotoxicity and regulates its accumulation in the heart.
Topics: Acute Disease; Animals; Antibiotics, Antineoplastic; Apigenin; Cardiotoxicity; Doxorubicin; Glucuronates; Injections, Intraperitoneal; Injections, Intravenous; L-Lactate Dehydrogenase; Male; Malondialdehyde; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2017 |